Eltrombopag Added to Standard Immunosuppressive Treatment Improves Long-Term Outcomes As Front-Line Therapy for Severe Aplastic Anemia: Final 2-Year Analysis of EBMT-Saawp Race Study
Antonio M. Risitano(European Society for Blood and Marrow Transplantation), Régis Peffault de Latour(Hôpital Saint-Louis), Jakob Passweg(University Hospital of Basel), Constantijn J.M. Halkes(Radboud University Nijmegen), Christian Récher(Institut universitaire du cancer de Toulouse Oncopole), Gèrard Socié(Hôpital Saint-Louis), Talha Munir(Leeds Teaching Hospitals NHS Trust), Jean-Baptiste Méar, Ghulam Mufti(King's College London), Aline Praire(Centre Hospitalier Universitaire de Toulouse), Florence Rabian(Assistance Publique – Hôpitaux de Paris), Morag Griffin(Leeds Teaching Hospitals NHS Trust), Petra Muus(Radboud University Nijmegen), Fabiana Cacace(Duke University), Isabel Sánchez‐Ortega(European Society for Blood and Marrow Transplantation), Wilma Barcellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Nigel H. Russell(Guy's and St Thomas' NHS Foundation Trust), Marica Laurino(Hospices Civils de Lyon), Walter Barberi(Policlinico Umberto I), Austin Kulasekararaj(King's College London), Fiorenza Barraco(Hôpital Lyon Sud), Serena Marotta(Centre Hospitalier Universitaire de Toulouse), Erfan Nur(Sanquin), Louis Terriou(Centre Hospitalier Universitaire de Lille), Camilla Frieri(Université Paris Cité), Elena Palmisani(Istituto Giannina Gaslini), Jennifer M.L. Tjon(Leiden University Medical Center), Anna Paola Iori(Sapienza University of Rome), Blanca Xicoy(Hospital Universitari Germans Trias i Pujol), Marco R. de Groot(University Medical Center Groningen), Emanuele Angelucci(Ospedale Policlinico San Martino), Reinier Raymakers(University Medical Center Utrecht), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Flore Sicre de Fontbrune(Assistance Publique – Hôpitaux de Paris), Marleen van Os(Universität Hamburg), Beatrice Drexler(University Hospital of Basel), Alexander J. Smith(Guy's Hospital), Édouard Forcade(Hôpital Cardiologique du Haut-Lévêque), Suzanne Tavitian(Institut universitaire du cancer de Toulouse Oncopole), Carlos Vallejo(Hospital General de Catalunya), Etienne Daguindau(Hôpital Privé Jean Mermo), Carlo Dufour(Istituto Giannina Gaslini), Laurence Clément(Centre Hospitalier Universitaire de Bordeaux), Judith Marsh(King's College London), Isidro Jarque Ramos, S. Iacobelli(University of Rome Tor Vergata), Anita Hill(Leeds Teaching Hospitals NHS Trust), Jamie Cavenagh(St Bartholomew's Hospital), Luana Marano(Centre Hospitalier Universitaire de Toulouse)
Cited by 1
Related Papers
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
|Nature|2010|1.3k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k